|
Price: $0.2584
$0.04 
17.401%
|
| Day's High:
| $0.2584
| Week Perf:
| 5.47 %
|
| Day's Low: |
$ 0.26 |
30 Day Perf: |
9.03 % |
| Volume (M): |
1 |
52 Wk High: |
$ 0.44 |
| Volume (M$): |
$ 0 |
52 Wk Avg: |
$0.19 |
| Open: |
$0.26 |
52 Wk Low: |
$0.05 |
|
|
| Market Capitalization (Millions $) |
5 |
| Shares
Outstanding (Millions) |
19 |
| Employees |
- |
| Revenues (TTM) (Millions $) |
2 |
| Net Income (TTM) (Millions $) |
0 |
| Cash Flow (TTM) (Millions $) |
0 |
| Capital Exp. (TTM) (Millions $) |
0 |
Qhslab Inc
Qhslab Inc is a technology company that specializes in developing and manufacturing innovative electronic products. The company is known for its cutting-edge research and development in the field of consumer electronics, with a focus on creating products that enhance people's daily lives. Qhslab Inc strives to provide high-quality and user-friendly devices that incorporate the latest advancements in technology. They are committed to staying at the forefront of the industry and continue to push boundaries in order to deliver innovative and reliable products to their customers.
Company Address: 901 Northpoint Parkway Beach 33407 FL
Company Phone Number: 379-6503 Stock Exchange / Ticker: USAQ
|
|
|
|
|
|
|
| Stock Performances by Major Competitors |
|
|
|
| Qhslab Inc
analyst focused on the Medical Equipment & Supplies industry, I am pleased to delve into the recent financial results of two key players, USAQ and Qhslab Inc. While Qhslab Inc showcases improving financial health, it is USAQ that stands out with its remarkable performance and a share price surge during the second quarter of 2024.
USAQ, a leading player in the industry, exhibited significant progress in their fiscal interval closing on March 31, 2024. They reported a per-share value of $0.00, indicating a considerable improvement from a negative $0.02 the previous year and negative $0.01 from the preceding period. This profitability milestone emphasizes the company's careful management and strategic planning, reaping rewards for their investors.
|
| Qhslab Inc
The stock market can be a daunting place for investors, with many factors influencing stock prices. One crucial aspect is evaluating a company's financial performance, as it provides valuable insights into its potential growth and stability. In this article, we will analyze Qhslab Inc's performance in the fourth quarter of 2023 and throughout the fiscal year, highlighting key facts and figures.
Fourth Quarter 2023 Results
In the fourth quarter of 2023, Qhslab Inc faced a net loss of $-0.087 million, a significant improvement from a deficit of $-0.216 million in the same period the previous year. This positive change indicates that the company has effectively managed its expenses and reduced losses.
|
| Qhslab Inc
Financial News Report: Qhslab Inc. Announces Surge in Revenue but Reports Net Deficit for Q3 2023
In the third quarter of 2023, Qhslab Inc., a Medical Equipment & Supplies company, revealed a significant surge in revenue of 24.908%, amounting to $0.34 million. This growth is in comparison to the same quarter of the previous year. However, the company reported a net deficit of $-0.082 million, resulting in a loss of $-0.01 per share in Q3 2023, which is the same loss per share as the comparable quarter a year ago.
On the other hand, when compared to the previous period, the loss per share remained flat at $-0.01, but the revenue experienced a decline of -16.889% from $0.40 million. Despite these setbacks, the company disclosed crucial additional innovations and highlighted their expansion in key areas, indicating a positive impact that is expected to exceed the time to come.
|
| Qhslab Inc
Qhslab Inc, a company operating in an undisclosed industry, reported mixed results for the fiscal second quarter of 2023. Despite a decrease in the loss per share compared to the previous year, the company still reported a net shortfall. On a positive note, the revenue increased significantly, indicating potential growth opportunities.
In terms of earnings per share, Qhslab Inc improved from a loss of $-0.02 per share in the preceding reporting season to a loss of $-0.01 per share in the second quarter of 2023. This demonstrates progress in the company's financial performance, although it is important to note that Qhslab Inc is still operating at a loss.
|
| Qhslab Inc
Qhslab Inc, a leading market player in the technology sector, has registered a positive upswing in its financial results for the fiscal year ending March 31 2023. The organization reported a decline in its losses per share from $-0.03 to $-0.02 compared to the previous year. Furthermore, it's noteworthy that there was a spectacular improvement in income per share, moving from $-0.03 to a positive number. This improvement is a testament to the efficacy of Qhslab Inc?s strategic planning and operational management, and it sets the foundation for continued growth and success in the future.
Another impressive aspect of Qhslab Inc?s financial year ending March 31 2023 is the growth of revenue. The company recorded a 6.914% increase in revenue, from $0.33 million in the corresponding reporting period of the previous year to $0.35 million. Furthermore, sequentially, revenue surged by 30.995%, from $0.27 million, undoubtedly, an outstanding and remarkable achievement.
|
| Per Share |
Current |
| Earnings (TTM) |
-0.02 $ |
| Revenues (TTM) |
0.09 $
|
| Cash Flow (TTM) |
- |
| Cash |
0.01 $
|
| Book Value |
-
|
| Dividend (TTM) |
0 $ |
|
|
| Per Share |
|
| Earnings (TTM) |
-0.02 $
|
| Revenues (TTM) |
0.09 $ |
| Cash Flow (TTM) |
- |
| Cash |
0.01 $
|
| Book Value |
- |
| Dividend (TTM) |
0 $ |
|
|
| |
| Allergy Diagnostic Kit Sales |
|
 40.44 % |
of total Revenue |
| Integrated Service Program |
|
29.72 % |
of total Revenue |
| Immunotherapy Treatment Sales |
|
11.74 % |
of total Revenue |
| Clinical Study Revenue |
|
13.64 % |
of total Revenue |
| Subscription Revenue |
|
2.36 % |
of total Revenue |
| Shipping and Handling |
|
1.5 % |
of total Revenue |
| Training Other Revenue |
|
0.61 % |
of total Revenue |
|
|
